Purchase Order 36C25025P0013

Award Date 10/15/24
Potential Completion Date 10/14/29
Potential Value $232K
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cleveland, OH 44106, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed price purchase order was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 to Cepheid for $86,448.70. The contract is for GeneXpert Analyzer equipment service to be performed at the Louis Stokes Cleveland VA Medical Center in Cleveland, Ohio from October 2023 through October 2024. The sole source award to Cepheid is to provide ongoing service and maintenance for GeneXpert Analyzers, which are molecular diagnostic...
The Department of Veterans Affairs (VA) has awarded a firm-fixed price purchase order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for a GeneXpert Infinity Service Contract. The contract, valued at $202,192.00, has an ultimate completion date of August 31, 2025 and will provide diagnostic testing equipment, reagents, consumables, and associated maintenance and support services to the VA's Cincinnati medical facility. This sole-source contract was awarded...
The Department of Veterans Affairs (VA) has awarded a Firm-Fixed Price Contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for a GeneXpert System Service Agreement at the Dayton VA Medical Center. The contract, valued at $147,830.00, has an ultimate completion date of January 31, 2030 and was awarded on February 1, 2025. The contract is not set aside and was awarded under FAR Subpart 13.2. Cepheid is the intended sole-source contractor for this agreement, as the...
The Department of Veterans Affairs (VA) has awarded a firm-fixed price purchase order to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the procurement of one GeneXpert GXIV-2-CLIA and one GeneXpert GXIV-4-CLIA analyzer. This sole source award, valued at $47,260.00, is intended to expand the capability of the existing Cepheid GeneXpert equipment used for various medical testing at the VA Northern Indiana Medical Center. The award does not have a set-aside...
This is a definitive, firm-fixed-price contract awarded by the Department of Veterans Affairs (VA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the provision of GeneXpert and GeneXpert Xpress maintenance and support services at VA medical facilities in Indiana. The contract, valued at $107,498.76, has a base period of one year and four one-year option periods, running through April 30, 2026. The contract was awarded on a sole-source basis, as Cepheid was...
This is a sole source contract awarded by the Department of Veterans Affairs (VA) Network Contracting Office 17 to Cepheid, a manufacturer of molecular diagnostic solutions, for the provision of maintenance services on GeneXpert instruments used at the Big Springs West TX VA Health Care System. The contract is a Firm Fixed Price Purchase Order with a base year plus four option years, and a total ceiling value of $65,002.50. There is no set-aside designation for this contract. Cepheid is the...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $249,994.80, is for annual preventative maintenance services on Cepheid's GeneXpert diagnostic equipment. The contract has a performance period of June 16, 2023 through June 15, 2028. This award is not associated with a set-aside program. Cepheid is the prime contractor and sole provider authorized to service...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for GeneXpert maintenance service. The contract has a ceiling value of $93,270.00 and a period of performance through February 14, 2030. Cepheid is a leading provider of molecular diagnostics to the VA, supplying the agency with GeneXpert diagnostic systems, reagents, and test kits to support clinical testing programs for...
This is a sole source federal contract award by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $126,647.10 firm-fixed price purchase order is for GeneXpert reagents and test kits to be used at the Buffalo VA Medical Center. The contract is not set aside. The VA indicates that Cepheid is the sole source for these supplies, as the VA's existing GeneXpert analyzers can only use OEM reagents and test...
The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price purchase order to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for full-service maintenance of Cepheid GeneXpert analyzers. The $240,500.40 contract has a completion date of October 18, 2025 and was awarded on October 19, 2020. This contract is not associated with a set-aside program. As the original equipment manufacturer, Cepheid provides reagents, test kits, instruments, and...

This is a sole-source, firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration's Network Contracting Office 10 to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $232,265.00 contract is for the maintenance and repair of Cepheid GeneXpert Xpress Analyzers at the Louis Stokes Cleveland VA Medical Center in Ohio. The award was made under FAR Subpart 13.2 and does not have a set-aside designation. Cepheid is the original equipment manufacturer and sole-source provider capable of meeting the VA's requirement. The contract has an ultimate completion date of October 14, 2029.

Generated 10/2/24, 10:44 AM